Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118297

Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.

J C Magee, B H Collins, R C Harland, B J Lindman, R R Bollinger, M M Frank, and J L Platt

Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

Find articles by Magee, J. in: PubMed | Google Scholar

Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

Find articles by Collins, B. in: PubMed | Google Scholar

Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

Find articles by Harland, R. in: PubMed | Google Scholar

Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

Find articles by Lindman, B. in: PubMed | Google Scholar

Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

Find articles by Bollinger, R. in: PubMed | Google Scholar

Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

Find articles by Frank, M. in: PubMed | Google Scholar

Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

Find articles by Platt, J. in: PubMed | Google Scholar

Published November 1, 1995 - More info

Published in Volume 96, Issue 5 on November 1, 1995
J Clin Invest. 1995;96(5):2404–2412. https://doi.org/10.1172/JCI118297.
© 1995 The American Society for Clinical Investigation
Published November 1, 1995 - Version history
View PDF
Abstract

Immunoglobulins regulate the complement system by activating complement on foreign surfaces and diverting reactive complement proteins away from autologous cell surfaces. Based on this model, we explored the ability of Ig to balance complement activation versus control in a pig-to-primate cardiac xenotransplantation model in which the binding of xenoreactive antibodies of the recipient to graft blood vessels and the activation of complement cause hyperacute rejection. Human IgG added to human serum caused a dose-dependent decrease in deposition of iC3b, cytotoxicity, and heparan sulfate release when the serum was incubated with porcine endothelial cells. This decrease was not caused by alteration in antibody binding or consumption of complement but presumably reflected decreased formation of C3 convertase on the endothelial cells. Infusion of purified human IgG into nonhuman primates prevented hyperacute rejection of porcine hearts transplanted into the primates. As expected, the transplants contained deposits of recipient Ig and C1q but not other complement components. The inhibition of complement on endothelial cell surfaces and in the xenotransplantation model supports the idea that IgG regulates the classical complement pathway and supports therapeutic use of that agent in humoral-mediated disease.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2404
page 2404
icon of scanned page 2405
page 2405
icon of scanned page 2406
page 2406
icon of scanned page 2407
page 2407
icon of scanned page 2408
page 2408
icon of scanned page 2409
page 2409
icon of scanned page 2410
page 2410
icon of scanned page 2411
page 2411
icon of scanned page 2412
page 2412
Version history
  • Version 1 (November 1, 1995): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts